Health Robotics' i.v.STATION Robot Beats IHS-RIVA Robot in Public Tenders at Two Additional Canadian Hospitals

Jun 25, 2012, 09:00 ET from Health Robotics

BOZEN, Sud-Tirol, Italy, June 25, 2012 /PRNewswire/ --

Health Robotics today announced that both Regina General Hospital and Pasqua Hospital from Regina Qu'Appelle Health Region (Saskatchewan) purchased 2 Health Robotics' i.v.STATION Robots through Health Robotics' exclusive partner Sandoz Canada, after Regina Qu'Appelle Health Region's extensive due diligence, site visits, and 1Q2012 direct comparisons between Canadian-based Intelligent Hospital Systems' RIVA and i.v.STATION.

Gaspar DeViedma, Health Robotics' Executive Vice President, stated: "This is certainly not the first time (nor do we expect it to be the last) where Health Robotics' competitors with outdated technologies [such as Intelligent Hospital Systems/RIVA or Loccioni/APOTECAchemo] dispute open-tender decisions and lose their appeals to such Public Tenders. These two companies seem more interested in trying to stop hospitals from adopting Health Robotics' 2nd Generation smaller, faster, and less expensive Robots through legal protests than in fixing their own obsolete Robots. In particular, RIVA had their own home country of Canada at their sole availability for 20+ years without competition, until Health Robotics entered the Canadian market with Sandoz in 2011. Canadian pharmacists (which arguably know RIVA the best) have continuously rejected RIVA, which only sold 2 Chemotherapy Robots in Canada in all this time, both through private contracts without competition, both prior to Sandoz entering the market, and none of which are "live" and operational today, even 2.5 years after RIVA's first press release."

For additional information on Regina Qu'Appelle Health Region's Tender Purchase justification of i.v.STATION Robots over RIVA's, please visit MERX Reference # 235557, or: (registration required). Intelligent Hospital Systems/Manrex officially protested Regina Qu'Appelle Health Region's decision and lost their appeal of the Public Tender Award to i.v.STATION.

Mr. DeViedma continued: "Within our small company's means, Health Robotics will continue to monitor the global IV Robotics market and to continue reporting to the general public on such instances where our competitors either challenge Public Tender decisions, or alternatively attempt to market their timeworn products by trying to avoid public scrutiny, offering incentives and compensation to hospital pharmacists' to purchase IV Robots without due diligence, as has been the case with IHS/RIVA and Loccioni/APOTECAchemo in a number of recent instances in the United States. Health Robotics on the other hand not only welcomes thorough product comparisons and due diligence, but also encourages pharmacists to do it."

About Health Robotics:

Founded in 2006, Health Robotics is the undisputed global leading supplier of life- critical intravenous medication robots, winning 100% of all worldwide I.V. Robot's publicly announced purchases in 2010 and 2011, and providing over 275 hospital installations in 5 continents with robotics-based technology and clinical software automation solutions. Health Robotics' world-leading solutions CytoCare® and i.v.STATION® ONCO [hazardous IVs], i.v.STATION® [non-hazardous IVs], i.v.SOFT® [workflow engine for sterile compounding], OMM® [Oncology Medication Management], MEDarchiver® [life-critical clinical information system], and TPNstation® [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' products help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit:

For additional information, please contact:
Luisa Celeghin
Phone (Canada): +1-289-470-1456
Phone (Europe): +39-0403-498-468

SOURCE Health Robotics